BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3592045)

  • 1. The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.
    Ferguson R; Grim CE; Opgenorth TJ
    Am J Public Health; 1987 Jul; 77(7):864-5. PubMed ID: 3592045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess incidence of treatment of end-stage renal disease in Mexican Americans.
    Pugh JA; Stern MP; Haffner SM; Eifler CW; Zapata M
    Am J Epidemiol; 1988 Jan; 127(1):135-44. PubMed ID: 3276155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system.
    Derose SF; Rutkowski MP; Crooks PW; Shi JM; Wang JQ; Kalantar-Zadeh K; Kovesdy CP; Levin NW; Jacobsen SJ
    Am J Kidney Dis; 2013 Aug; 62(2):236-44. PubMed ID: 23499049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States).
    Danley KL; Richardson JL; Bernstein L; Langholz B; Ross RK
    Cancer Causes Control; 1995 Nov; 6(6):492-8. PubMed ID: 8580296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of california cancer registry data, 1988-93.
    Cress RD; Holly EA
    Cancer Causes Control; 1997 Mar; 8(2):246-52. PubMed ID: 9134249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project.
    Frankenfield DL; Rocco MV; Frederick PR; Pugh J; McClellan WM; Owen WF
    Am J Kidney Dis; 1999 Oct; 34(4):721-30. PubMed ID: 10516355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.
    Cowie CC; Port FK; Wolfe RA; Savage PJ; Moll PP; Hawthorne VM
    N Engl J Med; 1989 Oct; 321(16):1074-9. PubMed ID: 2797067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third-World Hodgkin's disease at Los Angeles County-University of Southern California Medical Center.
    Hu E; Hufford S; Lukes R; Bernstein-Singer M; Sobel G; Gill P; Pinter-Brown L; Rarick M; Rosen P; Brynes R
    J Clin Oncol; 1988 Aug; 6(8):1285-92. PubMed ID: 3411341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence rates of the major leukemia subtypes among US Hispanics, Blacks, and non-Hispanic Whites.
    Matasar MJ; Ritchie EK; Consedine N; Magai C; Neugut AI
    Leuk Lymphoma; 2006 Nov; 47(11):2365-70. PubMed ID: 17107911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of depression in Los Angeles County.
    Frerichs RR; Aneshensel CS; Clark VA
    Am J Epidemiol; 1981 Jun; 113(6):691-9. PubMed ID: 7234858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: results from the 1997 ESRD Core Indicators Project. National ESRD Core Indicators Workgroup.
    Rocco MV; Frankenfield DL; Frederick PR; Pugh J; McClellan WM; Owen WF
    Perit Dial Int; 2000; 20(3):328-35. PubMed ID: 10898051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Correlates of CKD in Hispanics/Latinos in the United States.
    Ricardo AC; Flessner MF; Eckfeldt JH; Eggers PW; Franceschini N; Go AS; Gotman NM; Kramer HJ; Kusek JW; Loehr LR; Melamed ML; Peralta CA; Raij L; Rosas SE; Talavera GA; Lash JP
    Clin J Am Soc Nephrol; 2015 Oct; 10(10):1757-66. PubMed ID: 26416946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences.
    Wu X; Chen VW; Andrews PA; Ruiz B; Correa P
    Cancer Causes Control; 2007 Aug; 18(6):585-93. PubMed ID: 17406989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus.
    Sherman ME; Devesa SS
    Cancer; 2003 Jul; 98(1):176-86. PubMed ID: 12833470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and blacks.
    Gilliland FD; Becker TM; Key CR; Samet JM
    Cancer; 1994 Apr; 73(8):2192-9. PubMed ID: 8156525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-stage renal disease in US minority groups.
    Feldman HI; Klag MJ; Chiapella AP; Whelton PK
    Am J Kidney Dis; 1992 May; 19(5):397-410. PubMed ID: 1585925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community.
    Pugh JA; Medina RA; Cornell JC; Basu S
    Diabetes; 1995 Dec; 44(12):1375-80. PubMed ID: 7589841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic differences in hip fracture: a reduced incidence in Mexican Americans.
    Bauer RL
    Am J Epidemiol; 1988 Jan; 127(1):145-9. PubMed ID: 3337072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological correlates of NIDDM in Hispanics, whites, and blacks in the U.S. population.
    Harris MI
    Diabetes Care; 1991 Jul; 14(7):639-48. PubMed ID: 1914813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.